439 related articles for article (PubMed ID: 19058952)
41. Preparation and characterization of alginate/chitosan formulations for ciprofloxacin-controlled delivery.
Kyzioł A; Mazgała A; Michna J; Regiel-Futyra A; Sebastian V
J Biomater Appl; 2017 Aug; 32(2):162-174. PubMed ID: 28649925
[TBL] [Abstract][Full Text] [Related]
42. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
Luo Y; Wang Q
Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
[TBL] [Abstract][Full Text] [Related]
43. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency.
Takka S; Acartürk F
J Microencapsul; 1999; 16(3):275-90. PubMed ID: 10340214
[TBL] [Abstract][Full Text] [Related]
44. Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment.
Mukhopadhyay P; Maity S; Mandal S; Chakraborti AS; Prajapati AK; Kundu PP
Carbohydr Polym; 2018 Feb; 182():42-51. PubMed ID: 29279124
[TBL] [Abstract][Full Text] [Related]
45. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
46. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
47. A smart bioconjugate of alginate and pectinase with unusual biological activity toward chitosan.
Sardar M; Roy I; Gupta MN
Biotechnol Prog; 2003; 19(6):1654-8. PubMed ID: 14656137
[TBL] [Abstract][Full Text] [Related]
48. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
49. Alginate/quaternized carboxymethyl chitosan/clay nanocomposite microspheres: preparation and drug-controlled release behavior.
Liu B; Luo J; Wang X; Lu J; Deng H; Sun R
J Biomater Sci Polym Ed; 2013; 24(5):589-605. PubMed ID: 23565870
[TBL] [Abstract][Full Text] [Related]
50. Protein micro and nanoencapsulation within glycol-chitosan/Ca²+/alginate matrix by spray drying.
Erdinc B; Neufeld RJ
Drug Dev Ind Pharm; 2011 Jun; 37(6):619-27. PubMed ID: 21449696
[TBL] [Abstract][Full Text] [Related]
51. Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery.
Li XY; Li X; Kong XY; Shi S; Guo G; Zhang J; Luo F; Zhao X; Wei YQ; Qian ZY; Yang L
J Nanosci Nanotechnol; 2010 Aug; 10(8):4850-8. PubMed ID: 21125819
[TBL] [Abstract][Full Text] [Related]
52. Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation.
Sajeesh S; Sharma CP
J Biomater Appl; 2004 Jul; 19(1):35-45. PubMed ID: 15245642
[TBL] [Abstract][Full Text] [Related]
53. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology.
Nayak AK; Pal D
Int J Biol Macromol; 2011 Nov; 49(4):784-93. PubMed ID: 21816168
[TBL] [Abstract][Full Text] [Related]
54. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of uniform core-shell gelatin-alginate microparticles as intestine-released oral delivery drug carrier.
Huang KS; Yang CH; Kung CP; Grumezescu AM; Ker MD; Lin YS; Wang CY
Electrophoresis; 2014 Feb; 35(2-3):330-6. PubMed ID: 24002863
[TBL] [Abstract][Full Text] [Related]
56. Relating physicochemical properties of alginate-HMP complexes to their performance as drug delivery systems.
Liu CM; He XH; Liang RH; Liu W; Guo WL; Chen J
J Biomater Sci Polym Ed; 2017 Dec; 28(18):2242-2254. PubMed ID: 29037116
[TBL] [Abstract][Full Text] [Related]
57. Chitosan-alginate microparticles as a protein carrier.
Coppi G; Iannuccelli V; Leo E; Bernabei MT; Cameroni R
Drug Dev Ind Pharm; 2001 May; 27(5):393-400. PubMed ID: 11448046
[TBL] [Abstract][Full Text] [Related]
58. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
59. Quaternized chitosan-organic rectorite intercalated composites based nanoparticles for protein controlled release.
Xu R; Xin S; Zhou X; Li W; Cao F; Feng X; Deng H
Int J Pharm; 2012 Nov; 438(1-2):258-65. PubMed ID: 22982258
[TBL] [Abstract][Full Text] [Related]
60. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
Lakkakula JR; Matshaya T; Krause RW
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
